Product Information
DOFETILIDE 250 MCG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1886 per EA under NDC 47335006286. Its NADAC has been published 367 times since Feb 13, 2019.
FDA first approved this application on Oct 9, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the DOFETILIDE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.25 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335006286
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
DOFETILIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210466FDA Approved
10/9/2018
TE Code
AB
On Market Since
10/11/2018
Pharmacological Classes
Price Statistics
The NADAC for DOFETILIDE 250 MCG CAPSULE has been published 367 times since Feb 13, 2019, and over the history we have for it it has declined 94.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1886 per EA |
|---|---|
| All-time high | $3.7434 (Mar 13, 2019) |
| All-time low | $0.1886 (Feb 18, 2026) |
| 52-week high | $0.2178 |
| 52-week low | $0.1886 |
| Median price | $0.7762 |
| Average price | $1.0674 |
| Largest weekly change | +51.6% (Aug 17, 2022) |
| Weeks tracked | 367 |
| Tracking since | Feb 13, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-13.4%
3Y
-71.3%
5Y
-86.4%
All
-94.1%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOFETILIDE 250 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 250 MCG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.1886 per EA (NDC 47335006286), effective Feb 18, 2026.
How has the price of DOFETILIDE 250 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOFETILIDE 250 MCG CAPSULE has declined 94.1%. It has been tracked across 367 weekly CMS publications since Feb 13, 2019.
What are the highest and lowest recorded NADAC prices for DOFETILIDE 250 MCG CAPSULE?
Since Feb 13, 2019, the NADAC for DOFETILIDE 250 MCG CAPSULE has ranged from a low of $0.1886 (Feb 18, 2026) to a high of $3.7434 (Mar 13, 2019), with a median of $0.7762 per EA.
Are there cheaper alternatives to DOFETILIDE 250 MCG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOFETILIDE 250 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DOFETILIDE 250 MCG CAPSULE?
DOFETILIDE 250 MCG CAPSULE (NDC 47335006286) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.